{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:45:34Z","timestamp":1790595934882,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.bioorg.2023.106652","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:14:03Z","timestamp":1686568443000},"page":"106652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Improved anti-tumor activity of fluorinated camptothecin derivatives 9-fluorocamptothecin and 7-ethyl-9-fluorocamptothecin on hepatocellular carcinoma by targeting topoisomerase I"],"prefix":"10.1016","volume":"139","author":[{"given":"Mi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Zu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Xuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Peng","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Zeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Bo","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2023.106652_b0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"15","key":"10.1016\/j.bioorg.2023.106652_b0010","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Longo","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"10127","key":"10.1016\/j.bioorg.2023.106652_b0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106652_b0020","first-page":"413","article-title":"Hepatocellular carcinoma: diagnosis and proposal of treatment","volume":"107","author":"Testino","year":"2016","journal-title":"Minerva Med."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106652_b0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.28881","article-title":"Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database","volume":"65","author":"Parikh","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bioorg.2023.106652_b0030","unstructured":"Soc, J. A. C. <Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata. 1966."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106652_b0035","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/med.21342","article-title":"Perspectives on biologically active camptothecin derivatives","volume":"35","author":"Liu","year":"2015","journal-title":"Med. Res. Rev."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106652_b0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543770902773437","article-title":"Novel camptothecin derivatives as topoisomerase I inhibitors","volume":"19","author":"Basili","year":"2009","journal-title":"Expert Opin. Ther. Pat."},{"issue":"27","key":"10.1016\/j.bioorg.2023.106652_b0045","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106652_b0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/mol.52.1.82","article-title":"Novel 7-alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified mammalian topoisomerase I and in human colon carcinoma SW620 cells","volume":"52","author":"Valenti","year":"1997","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106652_b0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s002800000157","article-title":"Camptothecin analogues with enhanced antitumor activity at acidic pH","volume":"46","author":"Adams","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106652_b0060","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jvir.2015.03.020","article-title":"Transarterial hepatic chemoembolization with 70\u2013150 microm drug-eluting beads: assessment of clinical safety and liver toxicity profile","volume":"26","author":"Odisio","year":"2015","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"Suppl 6","key":"10.1016\/j.bioorg.2023.106652_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1634\/theoncologist.9-90006-33","article-title":"Topotecan in the first-line treatment of small cell lung cancer","volume":"9","author":"Stewart","year":"2004","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106652_b0070","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1054\/bjoc.2000.1303","article-title":"Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups","volume":"83","author":"Freyer","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106652_b0075","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/JTO.0b013e31824b23cb","article-title":"Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients","volume":"7","author":"Kim","year":"2012","journal-title":"J. Thorac. Oncol."},{"issue":"5846","key":"10.1016\/j.bioorg.2023.106652_b0080","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1126\/science.1131943","article-title":"Fluorine in pharmaceuticals: looking beyond intuition","volume":"317","author":"Muller","year":"2007","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.bioorg.2023.106652_b0085","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1021\/acs.jmedchem.9b01877","article-title":"Metabolic and Pharmaceutical Aspects of Fluorinated Compounds","volume":"63","author":"Johnson","year":"2020","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106652_b0090","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jm3012068","article-title":"Principles and applications of halogen bonding in medicinal chemistry and chemical biology","volume":"56","author":"Wilcken","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106652_b0095","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.pharmtox.41.1.443","article-title":"Metabolism of fluorine-containing drugs","volume":"41","author":"Park","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.bioorg.2023.106652_b0100","first-page":"2961","article-title":"Unusual potency of BN 80915, a novel fluorinated E-ring modified camptothecin, toward human colon carcinoma cells","volume":"61","author":"Larsen","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2023.106652_b0105","doi-asserted-by":"crossref","unstructured":"Jo, U.; Murai, Y.; Agama, K. K.; Sun, Y.; Saha, L. K.; Yang, X.; Arakawa, Y.; Gayle, S.; Jones, K.; Paralkar, V.; et al. TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Mol Cancer Ther 2022, 21 (7), 1090-1102. DOI: 10.1158\/1535-7163.MCT-21-1000.","DOI":"10.1158\/1535-7163.MCT-21-1000"},{"issue":"6","key":"10.1016\/j.bioorg.2023.106652_b0110","first-page":"1465","article-title":"Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and a relation to antitumor activity","volume":"49","author":"Jaxel","year":"1989","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106652_b0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0163-7258(95)02009-8","article-title":"Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives","volume":"68","author":"Rivory","year":"1995","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106652_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1568011053352596","article-title":"The impact of tumor physiology on camptothecin-based drug development","volume":"5","author":"Adams","year":"2005","journal-title":"Curr. Med. Chem. Anticancer Agents"},{"issue":"1","key":"10.1016\/j.bioorg.2023.106652_b0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1008027528218","article-title":"Comparative molecular field analysis and molecular modeling studies of 20-(S)-camptothecin analogs as inhibitors of DNA topoisomerase I and anticancer\/antitumor agents","volume":"11","author":"Carrigan","year":"1997","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106652_b0130","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/cr0780210","article-title":"Camptothecins: a SAR\/QSAR study","volume":"109","author":"Verma","year":"2009","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2023.106652_b0135","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.bmcl.2016.12.085","article-title":"The long story of camptothecin: From traditional medicine to drugs","volume":"27","author":"Martino","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"11","key":"10.1016\/j.bioorg.2023.106652_b0140","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/bi00437a018","article-title":"On the Mechanism of Topoisomerase-I Inhibition by Camptothecin - Evidence for Binding to an Enzyme DNA Complex","volume":"28","author":"Hertzberg","year":"1989","journal-title":"Biochemistry-Us"},{"key":"10.1016\/j.bioorg.2023.106652_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb07020.x","article-title":"Mechanism of action of camptothecin","volume":"922","author":"Liu","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2023.106652_b0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1743-7563.2012.01535.x","article-title":"MG132, a proteasome inhibitor, induces apoptosis in tumor cells","volume":"9","author":"Guo","year":"2013","journal-title":"Asia Pac. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2023.106652_b0155","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00018-015-2104-y","article-title":"Autophagy inhibitors","volume":"73","author":"Pasquier","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"20","key":"10.1016\/j.bioorg.2023.106652_b0160","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1016\/j.bmcl.2017.09.012","article-title":"Design, semisynthesis and potent cytotoxic activity of novel 10-fluorocamptothecin derivatives","volume":"27","author":"Yang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.bioorg.2023.106652_b0165","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1073\/pnas.242259599","article-title":"The mechanism of topoisomerase I poisoning by a camptothecin analog","volume":"99","author":"Staker","year":"2002","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bioorg.2023.106652_b0170","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/hep.22169","article-title":"Integration of genomic analysis and in vivo transfection to identify sprouty 2 as a candidate tumor suppressor in liver cancer","volume":"47","author":"Lee","year":"2008","journal-title":"Hepatology"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823003139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:18Z","timestamp":1758617178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823003139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"alternative-id":["S0045206823003139"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106652","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved anti-tumor activity of fluorinated camptothecin derivatives 9-fluorocamptothecin and 7-ethyl-9-fluorocamptothecin on hepatocellular carcinoma by targeting topoisomerase I","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106652"}}